MX2023011382A - Metodos y composiciones para mejorar la produccion y secrecion de insulina. - Google Patents
Metodos y composiciones para mejorar la produccion y secrecion de insulina.Info
- Publication number
- MX2023011382A MX2023011382A MX2023011382A MX2023011382A MX2023011382A MX 2023011382 A MX2023011382 A MX 2023011382A MX 2023011382 A MX2023011382 A MX 2023011382A MX 2023011382 A MX2023011382 A MX 2023011382A MX 2023011382 A MX2023011382 A MX 2023011382A
- Authority
- MX
- Mexico
- Prior art keywords
- improving insulin
- secretion
- compositions
- methods
- insulin production
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21382265 | 2021-03-31 | ||
| PCT/US2022/022712 WO2022212621A1 (en) | 2021-03-31 | 2022-03-31 | Methods and compositions for improving insulin production and secretion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023011382A true MX2023011382A (es) | 2023-10-06 |
Family
ID=75529926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023011382A MX2023011382A (es) | 2021-03-31 | 2022-03-31 | Metodos y composiciones para mejorar la produccion y secrecion de insulina. |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240065997A1 (enExample) |
| EP (1) | EP4312594A1 (enExample) |
| JP (1) | JP2024513816A (enExample) |
| CA (1) | CA3213326A1 (enExample) |
| MX (1) | MX2023011382A (enExample) |
| WO (1) | WO2022212621A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023183767A1 (en) * | 2022-03-21 | 2023-09-28 | Abbott Laboratories | Methods and compositions for increasing insulin sensitivity |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1131854B (it) * | 1980-06-30 | 1986-06-25 | Baldacci Lab Spa | Composizione farmaceutica per uso terapeutico,per uso diagnostico e quale integratore alimentare |
| JPH0647547B2 (ja) * | 1985-03-20 | 1994-06-22 | 大塚製薬株式会社 | 栄養補給飲食品 |
| AU784752B2 (en) * | 1999-10-18 | 2006-06-08 | Northern Innovations Holding Corp. | Food supplement for increasing lean mass and strength |
| JP4534579B2 (ja) * | 2004-04-28 | 2010-09-01 | 味の素株式会社 | リジン含有抗肥満または抗高脂血症用食品、飼料またはサプリメント |
| DK2381784T3 (en) * | 2008-12-09 | 2018-10-22 | Metabolic Tech Inc | Nutritional intervention to improve muscle function and strength |
| WO2013148685A1 (en) * | 2012-03-26 | 2013-10-03 | Abbott Laboratories | Pea protein containing nutritional compositions |
| WO2014152606A2 (en) * | 2013-03-14 | 2014-09-25 | Abbott Laboratories | Treatment of insulin resistance associated with prolonged physical inactivity |
| CN109090454A (zh) * | 2018-08-07 | 2018-12-28 | 广西弘山堂生物科技有限公司 | 一种猴菇养胃粉及其制备方法 |
-
2022
- 2022-03-31 EP EP22717328.3A patent/EP4312594A1/en active Pending
- 2022-03-31 MX MX2023011382A patent/MX2023011382A/es unknown
- 2022-03-31 JP JP2023560214A patent/JP2024513816A/ja active Pending
- 2022-03-31 US US18/552,726 patent/US20240065997A1/en active Pending
- 2022-03-31 WO PCT/US2022/022712 patent/WO2022212621A1/en not_active Ceased
- 2022-03-31 CA CA3213326A patent/CA3213326A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240065997A1 (en) | 2024-02-29 |
| WO2022212621A1 (en) | 2022-10-06 |
| CA3213326A1 (en) | 2022-10-06 |
| JP2024513816A (ja) | 2024-03-27 |
| EP4312594A1 (en) | 2024-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2021000028A1 (en) | Methods of reducing the need for peripheral arterial revascularization in a statin-treated subject | |
| MX2025009008A (es) | Cepas bacterianas probioticas que producen acidos grasos de cadena corta y composiciones que las comprenden | |
| MX2019010638A (es) | Modificadores de sabor para productos analogos de carne. | |
| NZ593145A (en) | Compositions with reduced dimer formation | |
| MX2017015037A (es) | Composiciones nutritivas que contienen un nivel elevado de inositol y usos de las mismas. | |
| MY207295A (en) | Method for preparing a composition comprising cetylated fatty acids | |
| MX2019005466A (es) | Composiciones y metodos para tratar diabetes, hipertension e hipercolesterolemia. | |
| AR119472A1 (es) | Composiciones y métodos para tratar la cavidad oral | |
| MY173927A (en) | Formula fortifier | |
| MX420109B (es) | Metodo para producir una composicion inmunogenica | |
| MX2020013988A (es) | Composiciones de acidos grasos poliinsaturados enriquecidos con dha. | |
| WO2023009759A3 (en) | Antibody-drug conjugates and methods of use thereof | |
| WO2013032558A4 (en) | Products for anti-inflammation support | |
| MX2023006086A (es) | Métodos para prevenir, retrasar o aliviar enfermedades atópicas. | |
| MX2026000276A (es) | Composiciones y metodos para tratar la esclerosis multiple | |
| WO2021260067A3 (en) | Method for the treatment of protein-containing compositions | |
| WO2021067611A3 (en) | Compositions and methods for treating alzheimer's disease | |
| AR117626A1 (es) | COMPOSICIÓN QUE COMPRENDE INHIBIDOR DE LA a-1 PROTEINASA ALTAMENTE CONCENTRADO Y PROCEDIMIENTO PARA LA OBTENCIÓN DE LA MISMA | |
| MX2023007791A (es) | Metodo para mejorar la salud de las articulaciones mediante la administracion de exosomas derivados de la leche bovina. | |
| PH12017502323A1 (en) | Novel xylanase | |
| CR20230257A (es) | Ésteres de ácidos dicarboxílicos para el tratamiento de enfermedades y padecimientos asociados con la toxina fosfolipasa d | |
| MX2021015732A (es) | Administracion intranasal de merotocina para mejorar la lactancia. | |
| GEAP202515919A (en) | Immunogenic compositions against enteric diseases and methods for its preparation thereof | |
| MX2021005776A (es) | Formulaciones farmaceuticas para administracion subcutanea. | |
| ZA202402369B (en) | Compositions and methods for treating or preventing inflammatory diseases including diabetes and thyroid diseases |